The use of left-sided Impella microaxial flow pumps has expanded rapidly for the management of cardiogenic shock, left ...

Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin Neuroscience's proprietary waveform technology.

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

Avon Medical Practice has launched a N200 million fully equipped Intensive Care Unit operating 24/7 with a dedicated team and ...

Rising metabolic disorders in India are fuelled by genetic predisposition, rapid lifestyle changes and hidden risk factors.

The AHA is expanding its initiative to improve detection, standardize care, and enhance treatment for hypertrophic cardiomyopathy.

The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

In direct alignment with the ACC’s call for rigorous quality assurance, reproducible results, and “human in the loop” analysis, Heartflow delivers a differentiated standard for clinical plaque ...

The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...

Detailed price information for Ventripoint Diagnostics Ltd (VPT-X) from The Globe and Mail including charting and trades.

While the potential benefits of AI in obesity prevention are substantial, the study devotes significant attention to ...